|本期目录/Table of Contents|

[1]韩飞 综述,刘力 审校.血清N末端B型利钠肽在识别川崎病冠状动脉损伤中的研究进展[J].天津医科大学学报,2021,27(02):208.
点击复制

血清N末端B型利钠肽在识别川崎病冠状动脉损伤中的研究进展(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
27
期数:
2021年02期
页码:
208
栏目:
综述
出版日期:
2021-03-15

文章信息/Info

Title:
-
文章编号:
1006-8147(2021)02-0208-03
作者:
韩飞1 综述刘力2 审校
(1.天津医科大学研究生院,天津300070;2.天津市儿童医院免疫科,天津300074)
Author(s):
-
关键词:
川崎病心脏冠状动脉损害血清N末端B型利钠肽
Keywords:
-
分类号:
R725.9
DOI:
-
文献标志码:
A
摘要:
川崎病(KD)是一种病因未明的全身性血管炎,以心血管系统损害最为严重,未经正规治疗的患儿可发生冠状动脉损伤,早期诊断及时治疗,可降低冠状动脉损伤的发生率。血清N末端B型利钠肽(NT-proBNP)由心脏分泌,被认为在预测冠状动脉损伤方面具有较高价值,现就NT-proBNP在川崎病诊断、冠状动脉损害的意义及其参考界值的范围进行介绍。
Abstract:
-

参考文献/References:

[1] Mccrindle B W,Rowley A H,Newburger J W,et al. Diagnosis,treatment,and long-term management of kawasaki disease:a scientific statement for health professionals from the American Heart Association[J]. Circulation,2017,135(17):e927
[2] Yukie O,Yamada F,Kishimoto T,et al. Epidemiologic features of Kawasaki disease:winter versus summer[J]. Pediatr Int,2017, 59(7):821
[3] De Graeff N,Groot N,Ozen S,et al. European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative[J]. Rheumatology,2019,58(4):672
[4] Nakamura Y. Kawasaki disease:epidemiology and the lessons from it[J]. Int J Rheum Dis,2018,21(1):16
[5] Salgado A P,Ashouri N,Berry E K,et al. High risk of coronary artery aneurysms in infants younger than 6 months of age with kawasaki disease[J]. J Pediatr,2017,185:112
[6] 王亚洲,黄芩,李小明,等. 川崎病冠状动脉损害与发热持续时间的相关性[J]. 昆明医科大学学报,2020,41(2):87
[7] Chang L S,Hus Y W,Lu C C,et al. CYP2E1 gene polymorphisms related to the formation of coronary artery lesions in kawasaki disease[J]. Pediatr Infect Dis J,2017,36(11):1039
[8] Zha L T,Li S T,Xin L,et al. Association of miR-146a gene polymorphism at loci rs2910164 G/C,rs57095329 A/G,and rs6864584 T/C with susceptibility to kawasaki disease in Chinese children[J]. Pediatr Cardiol,2019,40(3):504
[9] Bold A D,Borenstein H B,Veress A T,et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats[J]. Life Sci,1981,28(1):89
[10] Sudoh T,Kangawa K,Minamino N,et al. A new natriuretic peptide in porcine brain[J]. Nature,1988,332(6159):78
[11] Mckie P M,Burnett J C Jr. NT-proBNP the Gold standard biomarker in heart failure[J]. J Am Coll Cardiol,2016,66(22):2437
[12] Del Principe D,Pietraforte D,Gambardella L,et al. Pathogenetic determinants in Kawasaki disease:the haematological point of view[J]. J Cell Mol Med,2017,21(4):632
[13] Kenneth K M,Ogawa T,Adolfo J B. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase[J]. J Mol Cell Cardiol,2004,36(4):505
[14] Yanagisawa D,Ayusawa M,Kato M,et al. Factors affecting N-terminal pro-brain natriuretic peptide elevation in the acute phase of Kawasaki disease[J]. Pediatr Int,2016,58(11):1105
[15] Mueller K,Thiel F,Beutner F,et al. Brain damage with heart failure:cardiac biomarker alterations and gray matter decline[J]. Circ Res,2020,126(6):750
[16] Mcneal-Davidson A,Fournier A,Spigelblatt L A,et al. Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease[J]. Pediatr Int,2012,54(5):627
[17] Matsuura H,Ishikita T,Yamamoto S,et al. Gallium-67 myocardial imaging for the detection of myocarditis in the acute phase of Kawasaki disease (mucocutaneous lymph node syndrome): the usefulness of single photon emission computed tomography[J]. Heart,1987,58(4):385
[18] Harada M,Yokouchi Y,Oharaseki T,et al. Histopathological characteristics of myocarditis in acute-phase Kawasaki disease[J]. Histopathology,2012,61(6):1156
[19] Kang J H,Lee D S,Seo I A,et al. Early detection of kawasaki disease in infants[J]. Circulation,2015,131(2):510
[20] Kato M,Ayusawa M,Watanabe H,et al. Cardiac function on 3-D speckle tracking imaging and cytokines in Kawasaki disease[J]. Pediatr Int,2018,60(4):342
[21] Song H B,Zhang Y D,Dong Q W,et al. Significance of serum NT-proBNP and endogenous H2S for predicting coronary artery lesions in pediatric kawasaki disease[J]. J Coll Physicians Surg Pak,2020, 30(1):37
[22] 杨芳,王晓莉,欧宓,等.N端脑钠肽前体与超声心动图对川崎病的早期诊断对比研究[J].中华实用儿科临床杂志,2019,34(23):1803
[23] 刘力. 川崎病休克综合征的早期识别与处理[J]. 中国小儿急救医学,2020,27(5):346
[24] Kim M K,Song M S,Kim G B. Factors predicting resistance to intravenous immunoglobulin treatment and coronary artery lesion in patients with kawasaki disease:analysis of the korean nationwide multicenter survey from 2012 to 2014[J]. Korean Circ J,2018,48(1):71
[25] Nir A,Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology[J]. J Card Fail,2005,11(5,S):S76
[26] Nir A,Lindinger A,Rauh M,et al. NT-Pro-B-type natriuretic peptide in infants and children:reference values based on combined data from four studies[J]. Pediatr Cardiol,2009,30(1):3
[27] Kwon H,Lee J H,Jung J Y,et al. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease[J]. Eur J Pediatr,2016,175(12):1997
[28] Reddy M,Singh S,Rawat A,et al. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease[J]. Rheumatol Int,2016,36(4):551
[29] Satoh K,Wakejima Y,Gau M,et al. Risk of coronary artery lesions in young infants with Kawasaki disease:need for a new diagnostic method[J]. Int J Rheum Dis,2018,21(3):746
[30] 张帆.血清Nt-proBNP在小儿川崎病中的浓度变化研究分析[J].吉林医学,2019,40(6):1237

相似文献/References:

[1]王晓晓,周宇辉,王 倩,等.氨基末端脑钠肽前体水平对丙种球蛋白无反应性川崎病的预测价值[J].天津医科大学学报,2016,22(06):502.
 WANG Xiao-xiao,ZHOU Yu-hui,WANG Qian,et al.Predictive value of plasma brain natriuretic peptide in IVIG-resistant Kawasaki disease[J].Journal of Tianjin Medical University,2016,22(02):502.
[2]王 茜,周宇辉,王雨婷,等.川崎病并发冠状动脉损害危险因素的探讨[J].天津医科大学学报,2020,26(01):56.
 WANG Xi,ZHOU Yu-hui,WANG Yu-ting,et al.Risk factors of complicated coronary artery lesion in Kawasaki disease[J].Journal of Tianjin Medical University,2020,26(02):56.

备注/Memo

备注/Memo:
作者简介 韩飞(1990-),男,硕士在读,研究方向:小儿内科免疫;通信作者:刘力,E-mail: may13_cn@126.com。
更新日期/Last Update: 2021-03-10